We Cater to the ‘Un-Met Needs’ of the Patient
Globalpharma is a wholly owned subsidiary of Dubai Investments PJSC. Established in 1998, Globalpharma is currently a market leader in key generic pharma segments with a strong regional footprint. Globalpharma started its operations in the UAE in 2003 and expanded its growth in 2008 with product line extensions and New product launches across 14 countries in the GCC and select African markets. Currently Globalpharma has two Manufacturing plants, A state of the art Beta-Lactam Penicillin Manufacturing plant providing the Amoxicillin & AmoxiClav brands in the larger MENA region. Additionally, catering to the Lifestyle disease segments, is a General Medicine Manufacturing Plant with a variety of Liquid & Oral Solid Dose capabilities.
Globalpharma’s manufacturing facilities are cGMP (current Good Manufacturing Practice) certified, approved by all health authorities in the Middle-East (GCC, UAE, Saudi FDA), Levant, Africa and CIS regions.
Globalpharma manufactures and distributes Generic pharmaceutical products in almost all Lifestyle disease segments, including Cardiovasculars, Anti-ulcerants, Anti-Diabetics, Anti-Arthritis, Analgesics including NSAIDs (Nonsteroidal anti-inflammatory drugs), Respiratory, Anti-histamine formulations, Anti-infectives and Mulitvitamin supplements. The Company constantly focusses on continuously expanding its portfolio of covered therapeutic areas launching new products to meet the “Un-Met Needs” of the Patient.
Company’s flagship brands include Gloclav® (Amoxiclav) tablets and Oral Suspensions, Glomox® (Amoxicilin) Capsule, Tablets & Oral Suspensions, Emifenac® DT (Diclofenac dispersible Tab), Emidol® tablets and Glovit® Softgels in the Multivitamin range, and all of these are well respected brands across the Middle East & North African markets and trusted by health care professionals for their Quality and proven efficacy.
Additionally, Globalpharma is committed to supporting healthcare professionals in the UAE and the region by strengthening their knowledge and skills as part of its long-term focus on promoting Continuous Medical Education (CME) in the region.